Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report [Bevacizumab como opción terapéutica en sangrado gastrointestinal asociado a telangiectasia hemorrágica hereditaria. Reporte de caso]
TY - GEN
T1 - Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report [Bevacizumab como opción terapéutica en sangrado gastrointestinal asociado a telangiectasia hemorrágica hereditaria. Reporte de caso]
AU - Castillo E.
AU - Prada-Arismendy J.
Y1 - 2019
UR - http://hdl.handle.net/20.500.12622/3143
AB -
ER -
@misc{20.500.12622_3143,
author = {Castillo E. and Prada-Arismendy J.},
title = {Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report [Bevacizumab como opción terapéutica en sangrado gastrointestinal asociado a telangiectasia hemorrágica hereditaria. Reporte de caso]},
year = {2019},
abstract = {},
url = {http://hdl.handle.net/20.500.12622/3143}
}RT Generic
T1 Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report [Bevacizumab como opción terapéutica en sangrado gastrointestinal asociado a telangiectasia hemorrágica hereditaria. Reporte de caso]
A1 Castillo E.
A1 Prada-Arismendy J.
YR 2019
LK http://hdl.handle.net/20.500.12622/3143
AB
OL Spanish (121)